Evidence map›Paper›PMID 27465396›Full record

ReviewNeurochemical research2017

Neurotoxicity of Ammonia.

Simo S Oja, Pirjo Saransaari, Esa R Korpi

Open access · greenAbstract readReview
PubMed Publisher
In one paragraph

Review in Neurochemical research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 80 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Hydrogen Sulfide (HCurrent neuropharmacology · 2022
    Review
  15. Review
  16. Article
  17. Article
  18. Acidosis, cognitive dysfunction and motor impairments in patients with kidney disease.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2021
    Review
  19. Article
  20. The neurogliovascular unit in hepatic encephalopathy.JHEP reports : innovation in hepatology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Simo S OjaMedical School, 33014, University of Tampere, Finland. simo.oja@uta.fi.
Pirjo SaransaariMedical School, 33014, University of Tampere, Finland.
Esa R KorpiDepartment of Pharmacology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Tampere University · FITampere University · FIUniversity of Helsinki · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Abnormal liver function has dramatic effects on brain functions. Hyperammonemia interferes profoundly with brain metabolism, astrocyte volume regulation, and in particular mitochondrial functions. Gene expression in the brain and excitatory and inhibitory neurotransmission circuits are also affected. Experiments with a number of pertinent animal models have revealed several potential mechanisms which could underlie the pathological phenomena occurring in hepatic encephalopathy.

Indexed as

AmmoniaAnimalsAstrocytesBrainCell SizeHepatic EncephalopathyHumansMitochondriaReactive Nitrogen SpeciesReactive Oxygen SpeciesReceptors, N-Methyl-D-AspartateAmmoniaReactive Nitrogen SpeciesReactive Oxygen SpeciesReceptors, N-Methyl-D-AspartateAstrocytesGlutamine-glutamate cycleHepatic encephalopathyMitochondriaN-methyl-D-aspartate receptorsReactive oxygen species

Identifiers

PMID27465396
OpenAlexW2483122334

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.